gefitinib has been researched along with salinomycin in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (salinomycin) | Trials (salinomycin) | Recent Studies (post-2010) (salinomycin) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 672 | 30 | 409 |
| Protein | Taxonomy | gefitinib (IC50) | salinomycin (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, BW; Hou, BX; Li, YW; Luo, XY; Ma, ZK; Nie, PP; Shi, XP; Zou, ZZ | 1 |
1 other study(ies) available for gefitinib and salinomycin
| Article | Year |
|---|---|
Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer.
Topics: Animals; Apoptosis; Cathepsin B; Cathepsin D; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Gefitinib; Humans; Lysosomes; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Pyrans; Quinazolines; Reactive Oxygen Species; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |